光学前臨床画像の世界市場2020-2027:製品タイプ別(デバイス、消耗品、ソフトウェア)、最終用途別、地域別

◆英語タイトル:Optical Preclinical Imaging Market Size, Share & Trends Analysis Report By Product Type (Device, Consumables, Software), By End Use, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20JN103
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年4月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2週間)
◆調査対象地域:クローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥618,800見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥722,800見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥930,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、光学前臨床画像の世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、製品タイプ別(デバイス、消耗品、ソフトウェア)分析、最終用途別分析、地域別分析、競争状況など、今後の市場展望をまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・光学前臨床画像の世界市場規模:製品タイプ別(デバイス、消耗品、ソフトウェア)
・光学前臨床画像の世界市場規模:最終用途別
・光学前臨床画像の世界市場規模:地域別
・競争状況
【レポートの概要】

The global optical preclinical imaging market size is expected to reach USD 543.0 million by the end of 2027, expanding at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.

For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.

Further key findings from the study suggest:

• North America accounted for the largest share in 2019 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects

• Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2019 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies

• The bioluminescence segment is expected to witness significant growth over the forecast period due to increasing adoption of bioluminescence technology to visualize and study disease processes in laboratory animals

• By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2019 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation

• The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes

• Leading players operating in the market for optical preclinical imaging include Bruker; Perkin Elmer, Inc.; MR Solutions; BioTek Instruments, Inc.; Milabs B.V.; Fujifilm Holdings Corporation; Magnetic Insight, Inc.; MBF Bioscience; and Mediso Ltd.

【レポートの目次】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. By Product type
1.1.2. By End-use
1.1.3. Country scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Optical Preclinical Imaging Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing number of pipeline drug candidates and drug development studies
3.4.1.2. Government initiatives and grant approvals to support preclinical research
3.4.1.3. Adoption of non-invasive imaging techniques focused on animal safety
3.4.2. Market restraint analysis
3.4.2.1. Increasing adoption of alternative preclinical imaging technologies
3.5. Optical Preclinical Imaging Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major deals & strategic alliances analysis
3.5.4. Market entry strategies
Chapter 4. Optical Preclinical Imaging Market: By Product Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Device
4.2.1. Fluorescence
4.2.2. Bioluminescence
4.3. Consumables
4.3.1. Fluorescence
4.3.1.1. Green fluorescent proteins
4.3.1.2. Red fluorescent proteins
4.3.1.3. Infrared dyes
4.3.1.4. Others
4.3.2. Bioluminescence
4.3.2.1. Luciferins
4.3.2.2. Proluciferins
4.3.2.3. Coelenterazine
4.3.2.4. Others
4.4. Software
4.5. By Product Type Market Share, 2019 & 2027
4.6. Segment Dashboard
4.7. Global Optical Preclinical Imaging by Product Type Outlook
4.7.1. Device
4.7.1.1. Device market estimates and forecast, 2016 – 2027 (USD Million)
4.7.1.2. Fluorescence
4.7.1.2.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.1.3. Bioluminescence
4.7.1.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2. Consumables
4.7.2.1. Consumables market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.2. Fluorescence
4.7.2.2.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.2.2. Green fluorescent proteins
4.7.2.2.2.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.2.3. Red fluorescent proteins
4.7.2.2.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.2.4. Infrared dyes
4.7.2.2.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.2.5. Others
4.7.2.2.5.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.3. Bioluminescence
4.7.2.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.3.2. Luciferins
4.7.2.3.2.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.3.3. Proluciferins
4.7.2.3.3.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.3.4. Coelenterazine
4.7.2.3.4.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.2.3.5. Luciferins
4.7.2.3.5.1. Market estimates and forecast, 2016 – 2027 (USD Million)
4.7.3. Software
4.7.3.1. Software market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 5. Optical Preclinical Imaging Market: By End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Pharma and biotech companies
5.1.2. Research institutes
5.1.3. Others
5.1. By End Use Market Share, 2019 & 2027
5.2. Segment Dashboard
5.3. Global Optical Preclinical Imaging by End-use Outlook
5.3.1. Pharma and biotech companies
5.3.1.1. Pharma and biotech companies market estimates and forecast, 2016 – 2027 (USD Million)
5.3.2. Research institutes
5.3.2.1. Research institutes market estimates and forecast, 2016 – 2027 (USD Million)
5.3.3. Others
5.3.3.1. Others market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 6. Optical Preclinical Imaging Market: Country Estimates & Trend Analysis
6.1. Country Market Share Analysis, 2019 & 2027
6.2. County Market Dashboard
6.3. Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2019
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East and Africa
6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.7.2. U.S.
6.7.2.1. U.S. market estimates and forecast, 2016 – 2027 (USD Million)
6.7.3. Canada
6.7.3.1. Canada market estimates and forecast, 2016 – 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.8.2. U.K.
6.8.2.1. U.K. market estimates and forecast, 2016 – 2027 (USD Million)
6.8.3. Germany
6.8.3.1. Germany market estimates and forecast, 2016 – 2027 (USD Million)
6.8.4. France
6.8.4.1. France market estimates and forecast, 2016 – 2027 (USD Million)
6.8.5. Italy
6.8.5.1. Italy market estimates and forecast, 2016 – 2027 (USD Million)
6.8.6. Spain
6.8.6.1. Spain market estimates and forecast, 2016 – 2027 (USD Million)
6.8.7. Russia
6.8.7.1. Russia market estimates and forecast, 2016 – 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.9.2. Japan
6.9.2.1. Japan market estimates and forecast, 2016 – 2027 (USD Million)
6.9.3. China
6.9.3.1. China market estimates and forecast, 2016 – 2027 (USD Million)
6.9.4. India
6.9.4.1. India market estimates and forecast, 2016 – 2027 (USD Million)
6.9.5. Thailand
6.9.5.1. Thailand market estimates and forecast, 2016 – 2027 (USD Million)
6.9.6. South Korea
6.9.6.1. South Korea market estimates and forecast, 2016 – 2027 (USD Million)
6.9.7. Malaysia
6.9.7.1. Malaysia market estimates and forecast, 2016 – 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.10.2. Brazil
6.10.2.1. Brazil market estimates and forecast, 2016 – 2027 (USD Million)
6.10.3. Mexico
6.10.3.1. Mexico market estimates and forecast, 2016 – 2027 (USD Million)
6.10.4. Argentina
6.10.4.1. Argentina market estimates and forecast, 2016 – 2027 (USD Million)
6.10.5. Columbia
6.10.5.1. Columbia market estimates and forecast, 2016 – 2027 (USD Million)
6.11. Middle East & Africa
6.11.1. Market estimates and forecast, 2016 – 2027 (USD Million)
6.11.2. South Africa
6.11.2.1. South Africa market estimates and forecast, 2016 – 2027 (USD Million)
6.11.3. Saudi Arabia
6.11.3.1. Saudi Arabia market estimates and forecast, 2016 – 2027 (USD Million)
6.11.4. UAE
6.11.4.1. Kuwait market estimates and forecast, 2016 – 2027 (USD Million)
6.11.5. Qatar
6.11.5.1. Qatar market estimates and forecast, 2016 – 2027 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2019
7.3.4. Bruker Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Procedure benchmarking
7.3.4.4. Strategic initiatives
7.3.5. PerkinElmer Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Procedure benchmarking
7.3.5.4. Strategic initiatives
7.3.6. MR Solutions
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Procedure benchmarking
7.3.6.4. Strategic initiatives
7.3.7. BioTek Instruments, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Procedure benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Milabs B.V.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Procedure benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Magnetic Insight, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Procedure benchmarking
7.3.9.4. Strategic initiatives
7.3.10. MBF Bioscience
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Procedure benchmarking
7.3.10.4. Strategic initiatives
7.3.11. FUJIFILM Holdings Corporation
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Procedure benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Mediso Ltd.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Procedure benchmarking
7.3.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America optical preclinical imaging market, by region, 2016 - 2027 (USD million)
Table 3 North America optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 4 North America optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 5 U.S. optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 6 U.S. optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 7 Canada optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 8 Canada optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 9 Europe optical preclinical imaging market, by region, 2016 - 2027 (USD million)
Table 10 Europe optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 11 Europe optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 12 U.K. optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 13 U.K. optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 14 Germany optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 15 Germany optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 16 Italy optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 17 Italy optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 18 Spain optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 19 Spain optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 20 France optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 21 France optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 22 Russia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 23 Russia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 24 Asia Pacific optical preclinical imaging market, by region, 2016 - 2027 (USD million)
Table 25 Asia Pacific optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 26 Asia Pacific optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 27 Japan optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 28 Japan optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 29 Japan others optical preclinical imaging market, by product, 2016 - 2027 (USD million)
Table 30 China optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 31 China optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 32 India optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 33 India optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 34 South Korea optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 35 South Korea optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 36 Thailand optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 37 Thailand optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 38 Malaysia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 39 Malaysia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 40 Latin America optical preclinical imaging market, by region, 2016 - 2027 (USD million)
Table 41 Latin America optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 42 Latin America optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 43 Brazil optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 44 Brazil optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 45 Mexico optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 46 Mexico optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 47 Argentina optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 48 Argentina optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 49 Columbia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 50 Columbia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 51 Middle East and Africa optical preclinical imaging market, by region, 2016 - 2027 (USD million)
Table 52 Middle East and Africa optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 53 Middle East and Africa optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 54 South Africa optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 55 South Africa optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 56 Saudi Arabia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 57 Saudi Arabia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 58 UAE optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 59 UAE optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
Table 60 Qatar optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
Table 61 Qatar optical preclinical imaging market, by end use, 2016 - 2027 (USD million)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[光学前臨床画像の世界市場2020-2027:製品タイプ別(デバイス、消耗品、ソフトウェア)、最終用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆